SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TOSHI

TOSHI is currently trending as its dedicated community remains highly engaged, actively accumulating the asset and expressing strong conviction despite broader market volatility. Chatter is focused on its role as the "Face of Base" and anticipation of future catalysts like potential Tier 1 exchange listings and the upcoming Toshi Mobile launch, reinforcing its long-term utility beyond a meme coin.

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Protagonist Therapeutics Inc

Protagonist Therapeutics is trending due to significant market chatter surrounding a potential acquisition by Johnson & Johnson, complementing its strong clinical pipeline. The community is highly engaged in discussions about J&J's strategic interest in PTGX's promising immunology and hematology assets, particularly the "practice-changing" rusfertide data and the efficacy of its oral IL-23 receptor antagonist, JNJ-2113.

Colliers International Group, Inc. engages in the provision of commercial real estate services to corporate and institutional clients. It offers outsourcing and advisory services, lease brokerage, and sales brokerage. It operates through the following segments: Real Estate Services, Engineering, Investment Management, and Corporate. The Real Estate Services segment relates to Americas, EMEA, and Asia Pacific regions. The Engineering segment refers to engineering and project management. The Investment Management segment is involved in a global alternative asset manager with long-standing, cycle tested expertise. The Corporate segment includes the costs of global administrative functions and corporate head office. The company was founded on July 31, 1988, and is headquartered in Toronto, Canada.

Colliers International Group Inc

Colliers International (CIGI) is trending due to its strategic partnership with Google Cloud, aimed at accelerating digital and AI-powered innovation within the commercial real estate sector. The community sees this as a pivotal move into AI infrastructure, positioning Colliers for market leadership in this evolving space. Ongoing analyst interest is also evident, reflecting the company's broader strategy of diversifying services through targeted acquisitions.

Volatility Shares Trust - Volatility Shares Trust XRP ETF

XRP ETF

XRPI is trending as investors are actively discussing its potential as an XRP ETF, buoyed by recent reports of sustained positive net inflows since its inception. The community is anticipating significant upward movement, seeing current levels as a buying opportunity, and emphasizing Ripple's growing role in global payments as a key driver for the asset's long-term value.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

AIRCOIN CRYPTO is trending with strong community enthusiasm following the launch of its "AirLock" feature, enabling holders to lock tokens for rewards and achieve community-owned supply control. This initiative is driving significant bullish sentiment, as participants believe it fosters a long-term HODLing culture and represents a revolutionary approach for projects on the Solana blockchain.

Listed Funds Trust - Teucrium 2x Long Daily XRP ETF

The Teucrium 2x Long Daily XRP ETF

The Teucrium 2x Long Daily XRP ETF (XXRP) is highly active as investors eagerly anticipate upcoming XRP spot ETF launches, particularly from Canary Capital and 21Shares, along with the recent passage of the "Genius Act" in the House. Despite widespread discussion about the leveraged ETF's inherent volatility and decay, the community is actively buying significant dips, seeing them as opportunities for massive gains as they bet on XRP's broader adoption and a potential market surge.

Inflection Point Acquisition Corp. IV is a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Andrew Stephen Gundlach and Michel Combes on June 24, 2024 and is headquartered in New York, NY.

Inflection Point Acquisition Corp. IV - Ordinary Shares - Class A

Bleichroeder Acquisition Corp I

Bleichroeder Acquisition Corp I (BACQ) is trending after repeated bullish mentions from Citron Research, highlighting its anticipated merger with Merlin Labs, a defense technology company focused on AI-enabled autonomous flight. The community is actively discussing Merlin's significant government contracts and partnerships with major aerospace firms, seeing it as a compelling, undervalued opportunity in the national security and AI sectors with limited downside near its NAV.

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Exact Sciences Corp.

Exact Sciences is trending following its acquisition by Abbott Laboratories for $105 per share, a deal valued at approximately $21 billion. The community is actively discussing this major development in the cancer diagnostics sector, with many celebrating substantial long-term gains while evaluating their next investment moves given the significant buyout offer.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

Stellar Lumens (XLM) is trending amid significant developments, including U.S. Bank exploring stablecoin issuance on its network and WireX settling VISA payments with native stablecoins, boosting its institutional utility. The community is actively debating XLM's potential for a major breakout driven by these integrations and anticipated ISO 20022 compliance. However, discussions also reflect caution about broader crypto market volatility and comparisons with emerging high-throughput infrastructure projects.

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Quoin Pharmaceuticals Ltd - ADR

Quoin Pharmaceuticals is trending after announcing the successful achievement of target rapamycin loadings for two proprietary topical delivery technologies, advancing its rare disease pipeline. This news, coupled with its extremely low float and recent significant private placement funding, is driving intense community speculation about a potential short squeeze. Traders are actively debating its volatile price action and the possibility of substantial upside, comparing its potential to other low-float runners.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

💎 Liquid® Live Actionable Trade

Asset: $LWLG

Contracts: $LWLG January 15, 2027 $4 Calls

Scale in: $1.15- $1.40
Scale out: $4.46-$7.65

Profit Potential : 153% ROI Blended

Join 💎 Here: https://1iquid.com

1iquid

StockTwits Web

Lightwave Logic Inc

💎 Liquid® Live Actionable Trade

Asset: 

 January 15, 2027 $4 Calls

Scale in: $1.15- $1.40
Scale out: $4.46-$7.65

Profit Potential : 153% ROI Blended

Join 💎 Here: 